Q2 2026 Holdings
Filed 2026-08-14 | 73 holdings | $213.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $2.5M | 57,758 | 1.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $2.5M | 199,000 | 1.2% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $2.6M | 30,000 | 1.2% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $2.6M | 69,900 | 1.2% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.6M | 33,251 | 1.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.6M | 50,000 | 1.2% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $2.8M | 408,100 | 1.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.7M | 1,675,000 | 1.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.3M | 35,018 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.3M | 171,000 | 2.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.4M | 449,019 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.6M | 27,190 | 2.1% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $5.0M | 57,200 | 2.3% |
| Nektar Therapeutics(NKTR) | COM | 640268306 | $5.7M | 81,000 | 2.6% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $5.7M | 107,500 | 2.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $5.8M | 178,110 | 2.7% |
| Biodesix Inc | COM | 09075X108 | $6.5M | 286,804 | 3.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $6.7M | 666,196 | 3.1% |
| Intellia Therapeutics Inc(NTLA) | 45826J105 | 45826J105 | $6.8M | 385,900 | 3.2% |
| LAM Research Corporation(LRCX) | COM NEW | 512807306 | $15.2M | 35,000 | 7.1% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $17.1M | 297,243 | 8.0% |
| KLA Corporation(KLAC) | COM NEW | 482480100 | $53.8M | 178,471 | 25.2% |